Lung Cancer Screening: Who Should Ask About a Low-Dose CT?

1. Count pack-years, not just years smoked

A pack-year measures cigarette exposure: Multiply the average number of packs smoked per day by the number of years you smoked. One pack generally means 20 cigarettes. Smoking one pack daily for 20 years equals 20 pack-years; smoking half a pack daily for 40 years reaches the same total. This calculation is an eligibility tool, not a complete picture of your personal cancer risk.

If your smoking changed over time, calculate each period separately and add the results. For example, half a pack daily for 10 years contributes five pack-years. One pack daily for another 15 years contributes 15, producing a total of 20 pack-years. Years when you did not smoke add nothing, but they do not erase earlier exposure. Your quit date is recorded separately because some recommendations and coverage policies use it.

Bring your best estimate, even if your history is messy. A clinician can help reconstruct it without pretending the number is more precise than your memory.

• Ten cigarettes daily equals about half a pack; five daily equals about one-quarter.
• Write down starting and stopping ages, typical daily amounts, and extended breaks.
• Do not convert vaping, cigars, pipes or cannabis into cigarette pack-years yourself; standard eligibility formulas do not provide a reliable equivalent.

2. Know which recommendation you are discussing

Two influential U.S. recommendations agree on annual LDCT for many adults ages 50 through 80 with at least 20 pack-years. They differ on former smokers. The U.S. Preventive Services Task Force, or USPSTF, recommends screening for people who currently smoke or quit within the past 15 years. It advises stopping once someone has gone 15 years without smoking, or develops a health problem that substantially limits life expectancy or the ability or willingness to undergo curative lung surgery.

The American Cancer Society's 2023 guideline removed the years-since-quitting restriction. It recommends annual screening for adults ages 50 through 80 with at least 20 pack-years who currently or formerly smoked. Screening is not appropriate when serious health problems substantially limit life expectancy or the ability or willingness to receive treatment. This difference matters because aging can keep absolute lung cancer risk substantial even after years without cigarettes.

• Ask which guideline your clinician is using and why it fits your circumstances.
• If you quit more than 15 years ago, ask about the ACS recommendation rather than assuming screening is off the table.
• Family history, radon and workplace exposures deserve discussion, but do not automatically satisfy standard screening coverage criteria.

3. Check insurance separately from medical eligibility

A guideline is not a payment promise. Medicare's national screening coverage generally applies to people ages 50 through 77 who have no signs or symptoms of lung cancer, have at least 20 pack-years, and currently smoke or quit within the past 15 years. A clinician's order is required. Before the first screening, Medicare also requires a counseling and shared decision-making visit that addresses eligibility, benefits, harms, annual adherence and smoking cessation or continued abstinence.

Most non-grandfathered private health plans must cover USPSTF-recommended preventive services without patient cost-sharing when applicable requirements are met, generally using in-network providers. That does not mean every scan called preventive qualifies. An ACS-based recommendation for someone who quit 20 years ago may fall outside a plan's required preventive benefit. Medicaid coverage and administrative requirements can vary; Medicare Advantage plans may have network and authorization rules.

Before scheduling, have the ordering office and insurer confirm how the scan will be billed. Ask whether your age, pack-years and quit date qualify, whether the facility is in network, and whether authorization is needed. Separately ask about costs for follow-up imaging, specialist visits or biopsy after an abnormal scan: Those services may involve deductibles or coinsurance even when the initial screening has no cost-sharing. Request an estimate if coverage is uncertain.

4. Understand what the scan can and cannot do

LDCT produces detailed pictures of the lungs using less radiation than a conventional diagnostic chest CT. You lie on a table that moves through a short, doughnut-shaped scanner and briefly hold your breath. The scan itself takes only a short time; registration, positioning and discussion take longer. Routine screening LDCT generally does not require injected contrast, although a later diagnostic examination might.

The benefit comes from finding some cancers at an earlier, more treatable stage. It is not a guarantee: Screening can miss a cancer, and a cancer can develop between annual scans. A normal result does not mean you can ignore new symptoms. Chest X-rays are not a substitute for recommended LDCT lung cancer screening.

Screening is also a continuing process, not a one-time clearance. Annual scans are generally recommended while you remain eligible, but an abnormal finding can require an earlier repeat scan or additional testing. Before starting, consider whether you would be willing and medically able to pursue evaluation and treatment if cancer were found. You do not have to decide alone; the point of shared decision-making is to weigh your risk, other illnesses, preferences and the practical burden of returning for care.

5. Expect nodules, false alarms and incidental findings

LDCT often finds small lung nodules, or spots, and most are not cancer. They can reflect old infections, scars or other benign changes. A nodule may need comparison with older images or another CT to see whether it grows. An indeterminate finding is not a cancer diagnosis, and short-interval surveillance is not necessarily a sign that something dangerous was overlooked.

A false-positive result raises concern for cancer that ultimately is not present. It can lead to worry, repeat imaging and sometimes an invasive procedure. Needle biopsies and surgery have real risks, including bleeding, infection or a collapsed lung. Screening also exposes you to radiation; the dose is low, but repeated scans and additional imaging add exposure. Another harm is overdiagnosis: finding a cancer that would never have caused symptoms or shortened life, potentially leading to unnecessary treatment.

Incidental findings are different: They are abnormalities outside the main screening target, such as emphysema, coronary artery calcification or an adrenal nodule. Some are useful discoveries; others trigger testing without clear benefit. Many programs use Lung-RADS, a standardized reporting system that links findings to follow-up recommendations.

• Ask for the result category, recommended next step and exact follow-up timing.
• Arrange transfer of older chest scans so the radiologist can assess stability.
• Ask who will track incidental findings and whether additional testing would change your care.

6. Symptoms need diagnostic care, not a screening slot

Screening is intended for people without signs or symptoms suggesting lung cancer. If you have a new or persistent cough, a change in a chronic cough, coughing up blood, unexplained weight loss, persistent chest pain or worsening shortness of breath, contact a clinician for evaluation. These symptoms have many possible causes, but waiting for a routine annual screening appointment is not the right way to sort them out.

A diagnostic workup is tailored to the problem. Depending on your symptoms and examination, it may involve chest imaging, a different CT protocol, laboratory testing or referral. Do not ask that a symptom-driven test be labeled screening to obtain preventive coverage. The clinical purpose determines the appropriate order and billing, and diagnostic testing can have different insurance costs.

Your age or pack-year total should not prevent assessment of concerning symptoms. People who never smoked can develop lung cancer, too. Tell the scheduling staff what is happening rather than only requesting a scan. Coughing up more than a small streak of blood, severe breathing difficulty or significant chest pain warrants urgent medical attention; call 911 for severe or potentially life-threatening symptoms. A recent normal screening CT does not replace an evaluation of a new problem.

7. Leave the appointment with a workable plan

Bring your smoking timeline, quit date, insurance information and the location of any previous chest scans. Also discuss major medical conditions and what treatment you would consider if cancer were found. A good screening program helps coordinate results and follow-up, not just the initial appointment. Ask when to expect the report and whom to contact if it does not arrive.

If screening is recommended, confirm the next step before leaving: an order, any required counseling visit, insurance verification and a facility appointment. If it is not recommended, ask whether the reason is medical risk, likely benefit or a coverage restriction. Those are different issues. A coverage denial does not automatically mean screening lacks value, but paying out of pocket deserves a careful discussion of both benefit and downstream costs.

If you currently smoke, screening and quitting should proceed together. A CT does not cancel smoking's risks, and you do not have to succeed at quitting before discussing eligibility. Counseling and appropriate cessation medications can help. If you already quit, continued abstinence remains valuable regardless of which screening rule applies. The goal is a clear, individualized plan: screen when the expected benefit justifies it, investigate symptoms promptly, and make sure no recommended follow-up gets lost.